Ocular comfort of combination glaucoma therapies: Brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 4, 2007, Pages 372-376

  Chan, Kenny ^a   Testa, Madalena ^a   McCluskey, Peter ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BRIMONIDINE PLUS TIMOLOL; COMBIGAN; DORZOLAMIDE PLUS TIMOLOL; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT; BRIMONIDINE; DORZOLAMIDE; EYE DROPS; QUINOXALINE DERIVATIVE; SULFONAMIDE; THIOPHENE DERIVATIVE; TIMOLOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EYE DISCOMFORT; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; MALE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; PATIENT COMPLIANCE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUINOXALINES; SULFONAMIDES; THIOPHENES; TIMOLOL;

EID: 35848945084     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.0131     Document Type: Article

References (14)

1. Read, R.M., and Spaeth, G.L. The practical clinical appraisal of the optic disc in glaucoma: The natural history of cup progression and some specific disc-field correlations. Trans. Am. Acad. Ophthalmol. Otolaryngol. 78:255-274, 1974.
2. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130:429-440, 2000.
3. Tielsch, J.M., Katz, J., Singh, K., et al. A population-based evaluation of glaucoma screening: The Baltimore Eye Survey. Am. J. Epidemiol. 134:1102-1110, 1991.
4. Heijl, A., Leske, M.C., Bengtsson, B., et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol. 120:1268-1279, 2002.
5. Kass, M.A., Heuer, D.K., Higginbotham, E.J., et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120:701-716, 2002.
6. Nordstrom, B.L., Friedman, D.S., Mozaffari, E., et al. Persistence and adherence with topical glaucoma therapy. Am. J. Ophthalmol. 140:598-606, 2005.
7. Tsai, J.C., McClure, C.A., Ramos, S.E., et al. Compliance barriers in glaucoma: A systematic classification. J. Glaucoma 12:393-398, 2003.
8. Robin, A.L., and Covert, D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology 112:863-868, 2005.
9. Sleath, B., Robin, A.L., Covert, D., et al. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology 113:431-436, 2006.
10. Craven, E.R., Walters, T.R., Williams, R., et al., for the Combigan Study Group. Brimonidine and timolol fixed-combination therapy versus monotherapy: A 3-month randomized trial in patients with glaucoma or ocular hypertension. J. Ocul. Pharmacol. Ther. 21:337-348, 2005.
11. Boyle, J.E., Ghosh, K., Gieser, D.K., et al. A randomized trial comparing the dorzolamide-timolol combination given twice-daily to monotherapy with timolol and dorzolamide: The Dorzolamide-Timolol Study Group. Ophthalmology 105:1945-1951, 1998.
12. Strohmaier, K., Snyder, E., DuBiner, H., et al. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components: The Dorzolamide-Timolol Study Group. Ophthalmology 105:1936-1944, 1998.
13. Goni, F.J., and the Brimonidine/Timolol Fixed Combination Study Group. A 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension. Eur. J. Ophthalmol. 15:581-590, 2005.
14. Solish A.M., DeLucca P.T., Cassel D.A., et al. Dorzolamide/timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: A 3-month comparison of efficacy, tolerability, and patient-reported measures. J. Glaucoma. 13:149-157, 2004.